Biochemical characterisation of Troponin C mutations causing hypertrophic and dilated cardiomyopathies

Journal of Muscle Research and Cell Motility

Volumn 35, Issue 2, 2014, Pages 161-178

  Kalyva, Athanasia ^a   Parthenakis, Fragiskos I ^b   Marketou, Maria E ^b   Kontaraki, Joanna E ^a   Vardas, Panos E ^b  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Cardiac troponin C; Dilated cardiomyopathy; Hypertrophic cardiomyopathy; TnI phosphorylation

Indexed keywords

CALCIUM; TROPOMYOSIN; TROPONIN C;

AMINO ACID SEQUENCE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; CONGESTIVE CARDIOMYOPATHY; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; SKELETAL MUSCLE;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM; CARDIOMYOPATHY, DILATED; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; TROPOMYOSIN; TROPONIN C;

EID: 84904264796     PISSN: 01424319     EISSN: 15732657     Source Type: Journal    
DOI: 10.1007/s10974-014-9382-0     Document Type: Review

References (68)

1. Albury AN, Swindle N, Swartz DR, Tikunova SB (2012) Effect of hypertrophic cardiomyopathy-linked troponin C mutations on the response of reconstituted thin filaments to calcium upon troponin I phosphorylation. Biochemistry 51(17):3614-3621
2. Baryshnikova OK, Li MX, Sykes BD (2008a) Modulation of cardiac troponin C function by the cardiac-specific N-terminus of troponin I: influence of PKA phosphorylation and involvement in cardiomyopathies. J Mol Biol 375(3):735-751
3. Baryshnikova OK, Robertson IM, Mercier P, Sykes BD (2008b) The dilated cardiomyopathy G159D mutation in cardiac troponin C weakens the anchoring interaction with troponin I. Biochemistry 47(41):10950-10960
4. Biesiadecki BJ, Kobayashi T, Walker JS, Solaro RJ, de Tombe PP (2007) The troponin C G159D mutation blunts myofilament desensitization induced by troponin I Ser23/24 phosphorylation. Circ Res 100(10):1486-1493
5. Carballo S, Robinson P, Otway R, Fatkin D, Jongbloed JD, de Jonge N, Watkins H (2009) Identification and functional characterization of cardiac troponin I as a novel disease gene in autosomal dominant dilated cardiomyopathy. Circ Res 105(4):375-382
6. Chalovich JM, Eisenberg E (1986) The effect of troponin-tropomyosin on the binding of heavy meromyosin to actin in the presence of ATP. J Biol Chem 261(11):5088-5093
7. Chang AN, Harada K, Ackerman MJ, Potter JD (2005) Functional consequences of hypertrophic and dilated cardiomyopathy-causing mutations in alpha-tropomyosin. J Biol Chem 280(40):34343-34349
8. Cordina NM, Liew CK, Gell DA, Fajer PG, Mackay JP, Brown LJ (2013) Effects of calcium binding and the hypertrophic cardiomyopathy A8V mutation on the dynamic equilibrium between closed and open conformations of the regulatory N-domain of isolated cardiac troponin C. Biochemistry 52(11):1950-1962
9. Correlagen DI (2010) "Familial cardiomyopathy- an overview. cardiogenescan-cardiomyopathy-overview-050410"
10. Crilley JG, Boehm EA, Blair E, Rajagopalan B, Blamire AM, Styles P, Watkins H (2003) Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. J Am Coll Cardiol 41(10):1776-1782
11. Davis JP, Norman C, Kobayashi T, Solaro RJ, Swartz DR, Tikunova SB (2007) Effects of thin and thick filament proteins on calcium binding and exchange with cardiac troponin C. Biophys J 92(9):3195-3206
12. Dong WJ, Xing J, Ouyang Y, An J, Cheung HC (2008) Structural kinetics of cardiac troponin C mutants linked to familial hypertrophic and dilated cardiomyopathy in troponin complexes. J Biol Chem 283(6):3424-3432
13. Dweck D, Hus N, Potter JD (2008) Challenging current paradigms related to cardiomyopathies. Are changes in the Ca2 + sensitivity of myofilaments containing cardiac troponin C mutations (G159D and L29Q) good predictors of the phenotypic outcomes? J Biol Chem 283(48):33119-33128
14. Dweck D, Reynaldo DP, Pinto JR, Potter JD (2010) A dilated cardiomyopathy troponin C mutation lowers contractile force by reducing strong myosin-actin binding. J Biol Chem 285(23):17371-17379
15. Dyer EC, Jacques AM, Hoskins AC, Ward DG, Gallon CE, Messer AE, Marston SB (2009) Functional analysis of a unique troponin c mutation, GLY159ASP, that causes familial dilated cardiomyopathy, studied in explanted heart muscle. Circ Heart Fail 2(5):456-464
16. Ebashi S (1963) Third component participating in the superprecipitation of 'natural actomyosin'. Nature 200:1010
17. Ebashi S, Kodama A (1965) A new protein factor promoting aggregation of tropomyosin. J Biochem 58(1):107-108
18. el-Saleh SC, Potter JD (1985) Calcium-insensitive binding of heavy meromyosin to regulated actin at physiological ionic strength. J Biol Chem 260(27):14775-14779
19. Galinska A, Hatch V, Craig R, Murphy AM, Van Eyk JE, Wang CL, Foster DB (2010) The C terminus of cardiac troponin I stabilizes the Ca2 + -activated state of tropomyosin on actin filaments. Circ Res 106(4):705-711
20. Gollapudi SK, Chandra M (2012) Cardiomyopathy-related mutations in cardiac troponin C, L29Q and G159D, have divergent effects on rat cardiac myofiber contractile dynamics. Biochem Res Int 2012:824068
21. Harada K, Morimoto S (2004) Inherited cardiomyopathies as a troponin disease. Jpn J Physiol 54(4):307-318
22. Hernandez OM, Housmans PR (1985) Potter JD (2001) "Invited review: pathophysiology of cardiac muscle contraction and relaxation as a result of alterations in thin filament regulation.". J Appl Physiol 90(3):1125-1136
23. Hershberger RE, Norton N, Morales A, Li D, Siegfried JD, Gonzalez-Quintana J (2010) Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy. Circ Cardiovasc Genet 3(2):155-161
24. Herzberg O, James MN (1985) Structure of the calcium regulatory muscle protein troponin-C at 2.8 A resolution. Nature 313(6004):653-659
25. Hoffmann B, Schmidt-Traub H, Perrot A, Osterziel KJ, Gessner R (2001) First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy. Hum Mutat 17(6):524
26. Hongo K, Konishi M, Kurihara S (1994) Cytoplasmic free Mg2 + in rat ventricular myocytes studied with the fluorescent indicator furaptra. Jpn J Physiol 44(4):357-378
27. Kaski JP, Burch M, Elliott PM (2007) Mutations in the cardiac Troponin C gene are a cause of idiopathic dilated cardiomyopathy in childhood. Cardiol Young 17(6):675-677
28. Kranias EG, Solaro RJ (1982) Phosphorylation of troponin I and phospholamban during catecholamine stimulation of rabbit heart. Nature 298(5870):182-184
29. Landstrom AP, Parvatiyar MS, Pinto JR, Marquardt ML, Bos JM, Tester DJ, Ackerman MJ (2008) Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C. J Mol Cell Cardiol 45(2):281-288
30. Leblanc L, Bennet A, Borgford T (2000) Calcium affinity of regulatory sites in skeletal troponin-C is attenuated by N-cap mutations of helix C. Arch Biochem Biophys 384(2):296-304
31. Lehman W, Craig R (2008) Tropomyosin and the steric mechanism of muscle regulation. Adv Exp Med Biol 644:95-109
32. Li AY, Stevens CM, Liang B, Rayani K, Little S, Davis J, Tibbits GF (2013) Familial hypertrophic cardiomyopathy related cardiac troponin C L29Q mutation alters length-dependent activation and functional effects of phosphomimetic troponin I. PLoS ONE 8(11):e79363
33. Liang B, Chung F, Qu Y, Pavlov D, Gillis TE, Tikunova SB, Tibbits GF (2008) Familial hypertrophic cardiomyopathy-related cardiac troponin C mutation L29Q affects Ca2 + binding and myofilament contractility. Physiol Genomics 33(2):257-266
34. Lim CC, Yang H, Yang M, Wang CK, Shi J, Berg EA, Liao R (2008) A novel mutant cardiac troponin C disrupts molecular motions critical for calcium binding affinity and cardiomyocyte contractility. Biophys J 94(9):3577-3589
35. Lu QW, Wu XY, Morimoto S (2013) Inherited cardiomyopathies caused by troponin mutations. J Geriatr Cardiol 10(1):91-101
36. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Young JB (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113(14):1807-1816
37. Maron BJ, Gross BW, Stark SI (1995) Images in cardiovascular medicine. Extreme left ventricular hypertrophy. Circulation 92(9):2748
38. Marston SB (2011) How do mutations in contractile proteins cause the primary familial cardiomyopathies? J Cardiovasc Transl Res 4(3):245-255
39. McKillop DF, Geeves MA (1993) Regulation of the interaction between actin and myosin subfragment 1: evidence for three states of the thin filament. Biophys J 65(2):693-701
40. Memo M, Leung MC, Ward DG, dos Remedios C, Morimoto S, Zhang L, Messer AE (2013) Familial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca(2)(+) sensitivity. Cardiovasc Res 99(1):65-73
41. Mirza M, Marston S, Willott R, Ashley C, Mogensen J, McKenna W, Watkins H (2005) Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype. J Biol Chem 280(31):28498-28506
42. Mogensen J, Murphy RT, Shaw T, Bahl A, Redwood C, Watkins H, McKenna WJ (2004) Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 44(10):2033-2040
43. Neulen A, Stehle R, Pfitzer G (2009) The cardiac troponin C mutation Leu29Gln found in a patient with hypertrophic cardiomyopathy does not alter contractile parameters in skinned murine myocardium. Basic Res Cardiol 104(6):751-760
44. Palm T, Graboski S, Hitchcock-DeGregori SE, Greenfield NJ (2001) Disease-causing mutations in cardiac troponin T: identification of a critical tropomyosin-binding region. Biophys J 81(5):2827-2837
45. Parvatiyar MS, Landstrom AP, Figueiredo-Freitas C, Potter JD, Ackerman MJ, Pinto JR (2012) A mutation in TNNC1-encoded cardiac troponin C, TNNC1-A31S, predisposes to hypertrophic cardiomyopathy and ventricular fibrillation. J Biol Chem 287(38):31845-31855
46. (2+) affinity changes produced by hypertrophic cardiomyopathy cardiac troponin C mutants in myofilaments: a fast kinetic approach. J Biol Chem 286(2):1005-1013
47. Pinto JR, Siegfried JD, Parvatiyar MS, Li D, Norton N, Jones MA, Hershberger RE (2011b) Functional characterization of TNNC1 rare variants identified in dilated cardiomyopathy. J Biol Chem 286(39):34404-34412
48. Pinto JR, Parvatiyar MS, Jones MA, Liang J, Ackerman MJ, Potter JD (2009) A functional and structural study of troponin C mutations related to hypertrophic cardiomyopathy. J Biol Chem 284(28):19090-19100
49. Potter JD, Gergely J (1975) The calcium and magnesium binding sites on troponin and their role in the regulation of myofibrillar adenosine triphosphatase. J Biol Chem 250(12):4628-4633
50. Preston LC, Lipscomb S, Robinson P, Mogensen J, McKenna WJ, Watkins H, Redwood CS (2007a) Functional effects of the DCM mutant Gly159Asp troponin C in skinned muscle fibres. Pflugers Arch 453(6):771-776
51. Preston LC, Ashley CC, Redwood CS (2007b) DCM troponin C mutant Gly159Asp blunts the response to troponin phosphorylation. Biochem Biophys Res Commun 360(1):27-32
52. Redwood CS, Moolman-Smook JC, Watkins H (1999) Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. Cardiovasc Res 44(1):20-36
53. Robinson P, Mirza M, Knott A, Abdulrazzak H, Willott R, Marston S, Redwood C (2002) Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy. J Biol Chem 277(43):40710-40716
54. Robinson P, Griffiths PJ, Watkins H, Redwood CS (2007) Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments. Circ Res 101(12):1266-1273
55. Schmidtmann A, Lindow C, Villard S, Heuser A, Mugge A, Gessner R, Jaquet K (2005) Cardiac troponin C-L29Q, related to hypertrophic cardiomyopathy, hinders the transduction of the protein kinase A dependent phosphorylation signal from cardiac troponin I to C. FEBS J 272(23):6087-6097
56. Smith L, Greenfield NJ, Hitchcock-DeGregori SE (1994) The effects of deletion of the amino-terminal helix on troponin C function and stability. J Biol Chem 269(13):9857-9863
57. Solaro RJ, Rosevear P, Kobayashi T (2008) The unique functions of cardiac troponin I in the control of cardiac muscle contraction and relaxation. Biochem Biophys Res Commun 369(1):82-87
58. Sun YB, Lou F, Irving M (2009) Calcium- and myosin-dependent changes in troponin structure during activation of heart muscle. J Physiol 587(Pt 1):155-163
59. Swindle N, Tikunova SB (2010) Hypertrophic cardiomyopathy-linked mutation D145E drastically alters calcium binding by the C-domain of cardiac troponin C. Biochemistry 49(23):4813-4820
60. Szent-Gyorgyi AG (1975) Calcium regulation of muscle contraction. Biophys J 15(7):707-723
61. Takeda S, Yamashita A, Maeda K, Maeda Y (2003) Structure of the core domain of human cardiac troponin in the Ca2 + -saturated form. Nature 424(6944):35-41
62. Tikunova SB, Davis JP (2004) Designing calcium-sensitizing mutations in the regulatory domain of cardiac troponin C. J Biol Chem 279(34):35341-35352
63. Tripet B, Van Eyk JE, Hodges RS (1997) Mapping of a second actin-tropomyosin and a second troponin C binding site within the C terminus of troponin I, and their importance in the Ca2 + -dependent regulation of muscle contraction. J Mol Biol 271(5):728-750
64. van Spaendonck-Zwarts KY, van Tintelen JP, van Veldhuisen DJ, van der Werf R, Jongbloed JD, Paulus WJ, van den Berg MP (2010) Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation 121(20):2169-2175
65. (2+)-regulated structural changes in troponin. Proc Natl Acad Sci U S A 102(14):5038-5043
66. Watkins H, Conner D, Thierfelder L, Jarcho JA, MacRae C, McKenna WJ, Seidman CE (1995) Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet 11(4):434-437
67. 2+ sensitization and potentiation of the maximum level of myofibrillar ATPase activity caused by mutations of troponin T found in familial hypertrophic cardiomyopathy. J Biol Chem 274(13):8806-8812
68. 2+ sites on troponin C in the regulation of muscle contraction. Preparation and properties of troponin C depleted myofibrils. J Biol Chem 257(13):7678-7683